Melinta Therapeutics (United States)
Melinta Therapeutics is an American biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital settings. The company is located in Parsippany, New Jersey. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Melinta Therapeutics (United States), United States, covering academic research published from 2002 to 2024. Read More.
Open Access Percentage
66%
Total
Publications
163
Total Open
Publications
107
Total
Citations
4.9K
Open Access
Percentage
66%
Total
Publications
163
Total Open
Publications
107
Total
Citations
4.9K
Breakdown
Publisher Open
25%
Both
33%
Other Platform Open
7%
Closed
35%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 57%
53
Hybrid 19%
18
No Guarantees 24%
22
Other Platform Open
Domain 84%
56
Other Internet 15%
10
Institution 9%
6
Preprint 1%
1
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 55 |
DOI | Other Internet | 10 |
Europe PMC | Domain | 4 |
Pompeu Fabra University | Institution | 2 |
University of Udine | Institution | 1 |
University of Genoa | Institution | 1 |
Universitat Autònoma de Barcelona | Institution | 1 |
Universidad Nacional Autónoma de México | Institution | 1 |
iu.edu OAI-PMH Repository | Institution | 1 |
Indiana University | Institution | 1 |